A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Sumatriptan 50 mg Film-coated Tablets and Reference Product (IMIGRANâ„¢) in Healthy Thai Volunteers under Fasting Conditions : A Single Dose, Randomized, Open-label, Two-way CrossoverBioequivalence Study of Generic Sumatriptan 50 mg Film-coated Tablets and Reference Product (IMIGRANâ„¢) in Healthy Thai Volunteers under Fasting Conditions

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Bioequivalence Study, Healthy, Thai, Volunteers Sumatriptan, Bioequivalence Study, Healthy, Thai, Volunteers ;Sumatriptan, Bioequivalence Study, Healthy, Thai, Volunteers
Phase: Phase 1
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 21-06-2019, Last updated: 2023-06-05

ICTRP ID:

TCTR20190621002

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO005738598